Search results for " β"

showing 10 items of 113 documents

Protein and β-ODAP content and their association with yield contributing traits in selected grass pea lines

2009

Eight selected grass pea (Lathyrus sativus L.) lines were evaluated over three different growing seasons (2005-2008) at the experimental field at the ‘Sparacia farm’ (Cammarata-AG) in Sicily. A randomized complete-block design with three replicates was adopted. 35 viable seeds/m2 of each line were placed at the end of autumn in rows distant 50 cm. After one summer ploughing, 90 kg ha-1 di P2O5 were filled during two harrowing before sowing; later two manual weeds control were performed. Harvest was executed at full maturity of pods (end of the spring). Temperature values and effective rainfall for each season were recorded. Information are presented on the variability in storage seed protei…

Lathyrus sativus yield seed traits β-ODAP protein contentSettore AGR/02 - Agronomia E Coltivazioni Erbacee
researchProduct

Evaluation of the toxicity of mussels from 2 sites of the Moroccan Atlantic Coast (Jorf Lasfar and Oualidia) used as bioindicators of contamination :…

2012

Toxic substances generated by various human activities are spilled on different area of the Moroccan coast. Shellfishes can concentrate pollutants and have some adverse effects on human health through the food chain. Despite the strengthening of food safety rules, the involvement of chemical pollution of food on metabolic disorders is not known. To predict the impact of pollutants on the aquatic ecosystem and human health, the development of appropriate biomonitoring tools is required.We quantified heavy metals (Cd, Cr and Pb) in mussels (Mytilus galloprovincialis) from two sites of Moroccan Atlantic coast (industrial site Jorf Lasfar (JL) and touristic site Oualidia (OL)) due to the proxim…

Lipides (acides grasphytosterolsLipids (fatty acidsCytométrie en flux[ SDV.TOX.ECO ] Life Sciences [q-bio]/Toxicology/EcotoxicologyCytomicToxicologie (in vivo[ SDV.BBM.BC ] Life Sciences [q-bio]/Biochemistry Molecular Biology/Biomolecules [q-bio.BM]Β pancreatic murines (MIN-6) cellsMusselsin vitro)Flow cytometryMicroscopie[SDV.BBM.BC] Life Sciences [q-bio]/Biochemistry Molecular Biology/Biochemistry [q-bio.BM][SDV.BC] Life Sciences [q-bio]/Cellular BiologyphospholipidsMoulesMétaux lourdsMicroscopyChromatography[SDV.TOX.ECO] Life Sciences [q-bio]/Toxicology/Ecotoxicology[ SDV.BC ] Life Sciences [q-bio]/Cellular BiologycholesterolToxicology (in vivoHeavy metalsCytomiqueChromatographieoxysterolsCellules β pancréatiques murines (MIN-6)phospholipides
researchProduct

Nontumorous portal vein thrombosis in liver cirrhosis: Possible role of β-blockers

2018

<b><i>Objective:</i></b> Nonselective β-blockers (NSBB) are used in liver cirrhosis (LC) to prevent variceal bleeding because they decrease portal pressure. A main risk factor for the development of portal vein thrombosis (PVT) in LC is decreased portal vein inflow velocity. The aim of our study was to examine retrospectively the incidence of PVT and its correlation with the use of β-blockers in a cohort of LC patients. <b><i>Subjects and Methods:</i></b> Data from 230 LC patients (90% Child-Pugh class A), who had been followed up for at least 5 years, were reviewed. The diagnosis of PVT was made by ultrasound. The presence of PVT was evaluate…

Liver CirrhosisMalemedicine.medical_specialtyCirrhosisSettore MED/09 - Medicina InternaPortal venous pressureCirrhosis complicationAdrenergic beta-AntagonistsNonselective β-blockerGastroenterologySeverity of Illness Index03 medical and health sciences0302 clinical medicineEsophageal varicesRisk FactorsInternal medicineAscitesmedicineHumansRisk factorBleeding prevention therapyRisk of thrombosiAgedRetrospective StudiesAged 80 and overVenous ThrombosisUnivariate analysisOriginal Paperbusiness.industryPortal VeinIncidence (epidemiology)Medicine (all)General MedicineMiddle Agedmedicine.diseasePortal vein thrombosisLogistic ModelsItaly030220 oncology & carcinogenesis030211 gastroenterology & hepatologyFemalemedicine.symptombusiness
researchProduct

Impact of Resilience on the Association Between Amyloid-β and Longitudinal Cognitive Decline in Cognitively Healthy Older Adults

2019

The present study aims at investigating if the association between amyloid-β and longitudinal cognitive decline in cognitively healthy elderly is modulated by resilience capacity. Resilience capacity was quantified by education, which is a common proxy of resilience and has been shown to be related to a wide range of behaviors promoting resilience. Analyses were conducted with longitudinal cognitive data from the Alzheimer's Disease Neuroimaging Initiative (ADNI). 276 cognitively healthy older individuals (≥56 years) were included in the study. Baseline amyloid pathology was quantified using CSF amyloid-β 1-42 measurements. Longitudinal cognitive decline was assessed using ADAS13, Clinical …

Male0301 basic medicineGerontologyAmyloid pathologyAmyloid βClinical Dementia RatingDiseaseNeuropsychological Tests03 medical and health sciences0302 clinical medicineNeuroimagingAlzheimer Diseasemental disordersHumansMedicineCognitive DysfunctionLongitudinal StudiesCognitive declineAgedAged 80 and overAmyloid beta-Peptidesbusiness.industryGeneral NeuroscienceCognitionGeneral MedicineMiddle AgedResilience PsychologicalPeptide FragmentsPsychiatry and Mental healthClinical Psychology030104 developmental biologyMixed effectsFemaleGeriatrics and GerontologybusinessBiomarkers030217 neurology & neurosurgeryFollow-Up StudiesJournal of Alzheimer's Disease
researchProduct

Post-Mortem Immunohistochemical Evidence of β2-Adrenergic Receptor Expression in the Adrenal Gland

2019

The evidence from post-mortem biochemical studies conducted on cortisol and catecholamines suggest that analysis of the adrenal gland could provide useful information about its role in human pathophysiology and the stress response. Authors designed an immunohistochemical study on the expression of the adrenal &beta

Male0301 basic medicinePathologyGene ExpressionStimulationlcsh:Chemistry0302 clinical medicineCortex (anatomy)Adrenal Glandspost-mortem analysisReceptorlcsh:QH301-705.5SpectroscopyCause of deathAged 80 and overAdrenal glandβ2-adrenergic receptorsGeneral MedicineMiddle AgedPathophysiologyComputer Science Applicationsmedicine.anatomical_structureimmunohistochemistryImmunohistochemistryFemaleAutopsyAdultmedicine.medical_specialtyAdolescentBiologyArticleCatalysisInorganic ChemistryYoung Adult03 medical and health sciencesSettore MED/43 - Medicina LegalemedicineHumans030216 legal & forensic medicinepost-mortem analysiPhysical and Theoretical ChemistryMolecular BiologyAgedadrenal glandOrganic Chemistry030104 developmental biologylcsh:Biology (General)lcsh:QD1-999adrenal gland; immunohistochemistry; post-mortem analysis; β2-adrenergic receptorsReceptors Adrenergic beta-2HormoneInternational Journal of Molecular Sciences
researchProduct

Blockade of the trans-sulfuration pathway in acute pancreatitis due to nitration of cystathionine β-synthase

2019

© 2019 Published by Elsevier B.V.

Male0301 basic medicineS-AdenosylmethionineHomocysteineClinical BiochemistryNitric Oxide Synthase Type IINitrosative stressBiochemistryMicechemistry.chemical_compound0302 clinical medicineEdemaMedicineAcute inflammationHomocysteinelcsh:QH301-705.5lcsh:R5-920biologyGlutathioneUp-Regulationmedicine.anatomical_structureAcute pancreatitismedicine.symptomPancreaslcsh:Medicine (General)CeruletideResearch Papermedicine.medical_specialtyCystathionine beta-Synthase03 medical and health sciencesCystathionineInternal medicineAnimalsCysteineCystathionine β-synthaseS-adenosylmethionineMethioninebusiness.industryOrganic ChemistryGlutathionemedicine.diseaseCystathionine beta synthaseDisease Models Animal030104 developmental biologyEndocrinologyPancreatitischemistrylcsh:Biology (General)biology.proteinbusiness030217 neurology & neurosurgeryCysteineRedox Biology
researchProduct

MRI activity and neutralising antibody as predictors of response to interferon beta treatment in multiple sclerosis

2008

Objective: To prospectively validate MRI activity and neutralising anti-interferon antibody (NAb) during the first 6 months of interferon β treatment as response indicators in multiple sclerosis (MS). Methods: Patients with relapsing–remitting MS were followed during the first 2 years of treatment. Neurological assessments were performed every 3 months or when a relapse was suspected. MRI scans performed at baseline and at 3, 4, 5 and 6 months after the start of treatment were assessed centrally for disease activity: new T2 or gadolinium enhancing T1 lesions. NAb were assessed using the MxA protein assay; positivity was defined as two consecutive titres ⩾20 NU/ml. We evaluated the predictiv…

MaleNeutralising antibodyMULTICENTERPLACEBO-CONTROLLED TRIALGUIDELINESGastroenterologyDOUBLE-BLINDInterferon βMAGNETIC-RESONANCEProspective StudiesNeurologic ExaminationbiologyBrainIMPAIRMENTMiddle AgedPredictive valueMagnetic Resonance ImagingRecombinant ProteinsPsychiatry and Mental healthTreatment OutcomeSettore MED/26 - NeurologiaFemaleAntibodyInterferon beta-1bAdultmedicine.medical_specialtyDIAGNOSTIC-CRITERIAInjections SubcutaneousAntibodiesDrug Administration ScheduleDisease activityMultiple Sclerosis Relapsing-RemittingAdjuvants ImmunologicNeutralization TestsInternal medicinemedicineHumansInterferon betabusiness.industryMultiple sclerosisDISABILITYMSInterferon-betamedicine.diseaseConfidence intervalSurgerybiology.proteinSurgeryNeurology (clinical)businessFollow-Up Studies
researchProduct

Transforming growth factor β1 and additional renoprotective effect of combination ACE inhibitor and angiotensin II receptor blocker in hypertensive s…

2005

Objective To verify the benefit of renin–angiotensin system blockade in hypertension, the effects of 24 weeks’ losartan and ramipril treatment, both alone and in combination, on urinary albumin excretion (UAE) and circulating transforming growth factor b1 (TGFb1) have been evaluated in hypertensive subjects with minor renal abnormalities. Design and methods Fifty-one patients with stage 1 and 2 essential hypertension and with UAE >—20 mg/24 h but with maintained renal function have been included. After a 4-week run-in with placebo administration, a randomized double-blind, three-arm double-dummy trial was used. All the hypertensives (HT) were allocated randomly to three treatment arms (1…

MaleRamiprilmedicine.medical_specialtyAngiotensin receptorHypertension RenalPhysiologyAngiotensin-Converting Enzyme InhibitorsPharmacologyKidneySeverity of Illness IndexLosartanAce-inhibitors Angiotensin II receptor blockers hypertensive renal disease transforming growth factor β1.Transforming Growth Factor beta1transforming growth factor b1RamiprilTransforming Growth Factor betaInternal medicineInternal MedicinemedicineHumansRenal Insufficiencybusiness.industryMiddle AgedAngiotensin IIBlockadeangiotensin II receptor blockerEndocrinologyLosartanhypertensive renal diseaseRenal physiologyACE inhibitorDrug Therapy CombinationFemaleCardiology and Cardiovascular Medicinebusinessangiotensin-converting enzyme-inhibitorAngiotensin II Type 1 Receptor BlockersBiomarkersTransforming growth factormedicine.drug
researchProduct

Hematopoietic stem cell function in b-thalassemia is impaired and is rescued by targeting the bone marrow niche

2020

Abstract Hematopoietic stem cells (HSCs) are regulated by signals from the bone marrow (BM) niche that tune hematopoiesis at steady state and in hematologic disorders. To understand HSC-niche interactions in altered nonmalignant homeostasis, we selected β-thalassemia, a hemoglobin disorder, as a paradigm. In this severe congenital anemia, alterations secondary to the primary hemoglobin defect have a potential impact on HSC-niche cross talk. We report that HSCs in thalassemic mice (th3) have an impaired function, caused by the interaction with an altered BM niche. The HSC self-renewal defect is rescued after cell transplantation into a normal microenvironment, thus proving the active role of…

MaleStromal cellImmunologybone marrow mice thalassemia hematopoietic stem cells transplantation parathyroid hormoneSettore MED/08 - Anatomia PatologicaBiochemistryBone remodelingMiceBone MarrowmedicineAnimalsHumansOsteopontinStem Cell NicheHematopoietic stem cell β-thalassemia the bone marrow nichebiologybeta-ThalassemiaHematopoietic stem cellCell BiologyHematologyHematopoietic Stem CellsHematopoiesisMice Inbred C57BLTransplantationHaematopoiesismedicine.anatomical_structurebiology.proteinCancer researchFemaleBone marrowStem cell
researchProduct

Hydrolyzed infant formula and early β-cell autoimmunity: a randomized clinical trial.

2014

Importance The disease process leading to clinical type 1 diabetes often starts during the first years of life. Early exposure to complex dietary proteins may increase the risk of β-cell autoimmunity in children at genetic risk for type 1 diabetes. Extensively hydrolyzed formulas do not contain intact proteins. Objective To test the hypothesis that weaning to an extensively hydrolyzed formula decreases the cumulative incidence of diabetes-associated autoantibodies in young children. Design, Setting, and Participants A double-blind randomized clinical trial of 2159 infants with HLA-conferred disease susceptibility and a first-degree relative with type 1 diabetes recruited from May 2002 to Ja…

Maleinsulin-Secreting CellsautoantibodiesAutoimmunity2700 General MedicineGastroenterologylaw.invention0302 clinical medicineRandomized controlled trialnewbornlawCaseindouble-blind methodCumulative incidence030212 general & internal medicinehumans: Multidisciplinary general & others [D99] [Human health sciences]childHazard ratioGeneral Medicinefollow-up studiesInfant Formulaanimalscaseinstype 1femaleMilkbreast feedinghydrolysisdiabetes mellitusRiskmedicine.medical_specialty: Multidisciplinaire généralités & autres [D99] [Sciences de la santé humaine]β-cell autoimmunity610 Medicine & health030209 endocrinology & metabolismWeaningArticlehydrolyzed infant formula03 medical and health sciencesInternal medicineDiabetes mellitusHydrolyzed infant formula and early β-cell autoimmunitymedicineanimals; autoantibodies; breast feeding; caseins; child; diabetes mellitus; type 1; dietary proteins; double-blind method; female; follow-up studies; humans; hydrolysis; incidence; infant; newborn; insulin-Secreting Cells; Male; Milk; Risk; Weaning; Autoimmunity; Infant FormulaType 1 diabetesbusiness.industrydietary proteinsta1183Infant Newbornmedicine.diseaseta3123infantDiabetes Mellitus Type 1EndocrinologyInfant formula10036 Medical ClinicincidencebusinessBreast feeding
researchProduct